Cargando…

2543. Multisite Analysis of Vancomycin Predictions in a Bayesian Software in Patients with and without Acute Kidney Injury in Adult and Pediatric Patients

BACKGROUND: Inpatients that require vancomycin therapy often present with an acute kidney injury (AKI). Due to their unstable renal function, pharmacists hesitate to base dosing decisions on predictions provided by pharmacokinetic (PK) models within a Bayesian software. This study will therefore com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hughes, Maria-Stephanie, Hughes, Jasmine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677203/ http://dx.doi.org/10.1093/ofid/ofad500.2160

Ejemplares similares

1645. Predicting Vancomycin Area Under the Curve by Bayesian-Guided Dosing in Pediatric Patients
por: Shin, Donghyun, et al.
Publicado: (2023)

975. Age and Body Mass Index Impact Optimal Vancomycin Model Selection for Bayesian Dosing: Results from a Large Multi-site Retrospective Study of Adult Patients
por: Hughes, Maria-Stephanie, et al.
Publicado: (2023)

Impact of Vancomycin Serum Trough Concentrations and Vancomycin AUC/MIC on Vancomycin Response, In-Hospital Outcomes and Acute Kidney Injury in Pediatric Staphylococcus aureus Pneumonia
por: McNeil, Jonathon, et al.
Publicado: (2017)

609. Implementation of Bayesian Software for Vancomycin Dosing Integrated into an Electronic Medical Record
por: Jantrakul, Nicholas A, et al.
Publicado: (2021)

2543. Implementation of a Fellow-Driven Β-Lactam Allergy De-Labeling Initiative on an Inpatient ID Consult Service
por: Mulliken, Jennifer S, et al.
Publicado: (2019)

Vancomycin associated acute kidney injury in pediatric patients
por: Moffett, Brady S., et al.
Publicado: (2018)

610. Low Rates of Acute Kidney Injury (AKI) in Outpatient Vancomycin Managed by Pharmacists using Precision Dosing Software
por: Schroeder, Claudia P, et al.
Publicado: (2022)

67. Agreement Among Bayesian Dosing Software for Calculating Vancomycin Area Under the Curve
por: Pineda, Ross, et al.
Publicado: (2021)

Impact of Vancomycin-Associated Acute Kidney Injury on Patient Outcomes in MRSA Bacteremia
por: Luther, Megan, et al.
Publicado: (2017)

2543 High concentrations of CXCL12 decrease pancreatic adenocarcinoma growth
por: Vonderhaar, Emily, et al.
Publicado: (2018)

Comparison of Rates of Acute Kidney Injury with Vancomycin/Piperacillin-Tazobactam vs. Vancomycin/Meropenem Combination Therapy
por: Pernia, Sonia, et al.
Publicado: (2017)

Impact of Obesity on Acute Kidney Injury Incidence Among Patients Treated with Piperacillin–Tazobactam and Vancomycin
por: Rutter, W Cliff, et al.
Publicado: (2017)

1244. Evaluation of Intraoperative Topical Vancomycin and the Incidence of Acute Kidney Injury
por: Blackman, Alison L, et al.
Publicado: (2019)

1382. Acute Kidney Injury with Piperacillin–tazobactam and Vancomycin in the Intensive Care Unit
por: Smith, Tameka, et al.
Publicado: (2018)

Is There a Significant Difference in Acute Kidney Injury Incidence Among Patients Treated with Vancomycin Combined with Cefepime or Meropenem?
por: Rutter, W Cliff, et al.
Publicado: (2017)

PB2543: CIRCULATING MICROVESICLES AS POTENTIAL CELLULAR BIOMARKERS FOR THROMBOTIC RISKS IN BETA THALASSEMIA
por: Chebbi, Mariem, et al.
Publicado: (2023)

Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin/Tazobactam: Are Extended Infusions to Blame?
por: Navalkele, Bhagyashri, et al.
Publicado: (2015)

442. Risk Score for Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

Incidence of Acute Kidney Injury Among Intensive Care Unit Patients Receiving Vancomycin in Combination with Cefepime or Piperacillin–Tazobactam
por: Rutter, W Cliff, et al.
Publicado: (2017)

275. Evaluation of Vancomycin Prescribing Quality in Hospitalized Pediatric Patients
por: Abanyie-Bimbo, Francisca, et al.
Publicado: (2018)

610. Incidence of Acute Kidney Injury in Outpatient Parenteral Antimicrobial Therapy (OPAT) Patients Receiving Vancomycin
por: Hamad, Yasir, et al.
Publicado: (2020)

2292. Incidence of Acute Kidney Injury Associated with Duration of Vancomycin and Piperacillin/tazobactam Combination Therapy
por: McMullen, Lisanne, et al.
Publicado: (2019)

1335. A Translational Nephrotoxicity Model to Probe Acute Kidney Injury with Vancomycin and Piperacillin–Tazobactam
por: Pais, Gwendolyn M, et al.
Publicado: (2019)

1555. Risk of Developing Acute Kidney Injury in Patients Receiving Piperacillin–Tazobactam and Vancomycin Compared with Those on Piperacillin–Tazobactam and Telavancin
por: Reilly, Joseph, et al.
Publicado: (2019)

2558. Association of Vancomycin-Induced Acute Kidney Injury with Trough Versus AUC Monitoring in Patients Receiving Extended Durations of Therapy
por: Pitcock, C Tyler, et al.
Publicado: (2023)

2877. Influence of vancomycin AUC monitoring on acute kidney injury in a large quasi-experimental study of over 3000 patients
por: Gregory, Eric, et al.
Publicado: (2023)

212. Acute Kidney Injury with Piperacillin-tazobactam versus Cefepime in Combination with Vancomycin
por: Nguyen, Phuong Khanh, et al.
Publicado: (2020)

Acute Kidney Injury in Pediatric Patients Treated with Vancomycin and Piperacillin-Tazobactam Versus Vancomycin and Cefotaxime: A Single-center Study
por: Alqurashi, Rewaa, et al.
Publicado: (2020)

1568. The Pharmacodynamic–Toxicodynamic Relationship of AUC and CMAX in Vancomycin-Induced Kidney Injury
por: Avedissian, Sean N, et al.
Publicado: (2019)

2221. Comparison of Vancomycin with Either Piperacillin/Tazobactam or Cefepime for the Incidence of Acute Kidney Injury in a Patient Population with a High Prevalence of Preexisting Kidney Dysfunction
por: Moran, Ryan, et al.
Publicado: (2023)

1419. 24-Hour Pharmacokinetic Relationships for Intravenous Vancomycin and Novel Urinary Biomarkers of Acute Kidney Injury
por: Avedissian, Sean, et al.
Publicado: (2018)

1929. Risk of Acute Kidney Injury in Combat-Injured Patients Associated With Concomitant Vancomycin and Extended-Spectrum β-Lactam Antibiotic Use
por: Yabes, Joseph, et al.
Publicado: (2018)

Severe retinal degeneration in women with a c.2543del mutation in ORF15 of the RPGR gene
por: Kousal, Bohdan, et al.
Publicado: (2014)

Altered Pharmacokinetics Parameters of Vancomycin in Patients with Hematological Malignancy with Febrile Neutropenia, a Bayesian Software Estimation
por: Alzahrani, Abdullah M., et al.
Publicado: (2023)

50. Comparative Incidence of Acute Kidney Injury in Septic Patients Treated with Vancomycin in Combination with Piperacillin/Tazobactam vs. Cefepime
por: Deja, Erin, et al.
Publicado: (2020)

Renal function and biomarkers of acute kidney injury in pediatric patients
por: Málaga, Serafín
Publicado: (2015)

2669. Evaluation of Post-Operative Acute Kidney Injury with Piperacillin–Tazobactam Combined with Vancomycin for Lung Transplant Prophylaxis
por: Pettit, Natasha N, et al.
Publicado: (2019)

1552. Correlation Between Vancomycin Serum Trough Concentrations and Area Under the Curve in Pediatric Patients
por: Weaver, Krista, et al.
Publicado: (2019)

1642. Vancomycin AUC(24) Estimation Using First Order Pharmacokinetic Methods in Pediatric Patients
por: Wallace, Katie L, et al.
Publicado: (2023)

Acute Kidney Injury in Pediatric Treated with Vancomycin and Piperacillin-Tazobactam in Tertiary Care Hospital
por: Al Nuhait, Mohammed, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jdg6aah5lm31a2p8b39rs941qf